Health Care: Drugs

Supernus Pharmaceuticals Inc (SUPN: NASDAQ)

$11.78 n/a | n/a%
03/27/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 122.04M 12.02M 1.48M 803.00K
Cost of Sales 2.74M 1.10M 0.00 0.00
Gross Operating Profit 119.30M 10.92M 1.48M 803.00K
Selling, General, and Administrative Expenses 72.47M 55.59M 20.13M 7.93M
Research & Development 19.59M 17.24M 23.52M 30.63M
Operating Income before D & A (EBITDA) 27.25M -61.92M -42.17M -37.75M
Depreciation & Amortization 3.02M 3.78M 1.20M 1.10M
Interest Income 348.00K 299.00K 120.00K 31.00K
Other Income - Net 256.00K -22.80M -660.00K 117.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 24.83M -88.20M -43.91M -38.70M
Interest Expense 4.96M 7.85M 3.58M 1.87M
Pre-Tax Income 19.87M -96.05M -47.48M -40.57M
Income Taxes 0.00 0.00 0.00 -16.24M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 19.87M -92.27M -46.28M -23.22M
Net Income From Discontinued Operations 0.00 0.00 0.00 77.04M
Net Income From Total Operations 19.87M -92.27M -46.28M 53.82M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 19.87M -92.27M -46.28M 53.82M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
19.87M -92.27M -46.28M -23.22M
Preferred Dividends
Net Income Available To Common 19.87M -92.27M -47.43M -26.66M
Basic EPS from Continuing Ops. 0.47 -2.90 -2.72 -1.68
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 5.56
Basic EPS from Total Operations 0.47 -2.90 -2.72 3.88
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.47 -2.90 -2.72 3.88
Basic Normalized Net Income/Share 0.47 -2.90 -2.72 -1.68
EPS fr Continuing Ops. 0.39 -2.90 -2.72 -1.68
EPS fr Discontinued Ops 0.00 0.00 0.00 5.56
EPS fr Total Ops. 0.39 -2.90 -2.72 3.88
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) -0.07 0.00 0.00 0.00
EPS, Total 0.32 -2.90 -2.72 3.88
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.39 -2.90 -2.72 -1.68
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SUPN

Latest SUPN Headlines from TheStreet

More Financial News for SUPN

Press Releases for SUPN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter